Effect of SC-41930, a potent selective leukotriene B4 receptor antagonist, in the guinea pig model of middle ear inflammation

Annals of Otology, Rhinology and Laryngology

Volumn 105, Issue 6, 1996, Pages 476-480

  Sutbeyaz, Yavuz ^a,b,c   Yakan, Birkan ^a,b   Ozdemir, Hasan ^a,c   Karasen, Murat ^a,b   Doner, Fehmi ^a,b   Kufrevioglu, Irfan ^a,c  

^a Ataturk University ^*

^b ATATURK UNIVERSITY   (Turkey)

^c ATATÜRK UNIVERSITY   (Turkey)

Author keywords

animal model of otitis media; leukotriene; SC 41930

Indexed keywords

7 [3 (4 ACETYL 3 METHOXY 2 PROPYLPHENOXY)PROPOXY] 3,4 DIHYDRO 8 PROPYL 2H 1 BENZOPYRAN 2 CARBOXYLIC ACID; ARACHIDONIC ACID; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MYELOPEROXIDASE; PROSTAGLANDIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GUINEA PIG; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; TEMPORAL BONE;

EID: 8944245007     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949610500611     Document Type: Article

References (19)

1. Jung TTK, Park YM, Schlund D, et al. Effect of prostaglandin, leukotriene, and arachidonic acid on experimental otitis media with effusion in chinchillas. Ann Otol Rhinol Laryngol 1990;99(suppl 148):28-32.
2. Jung TTK. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media. Laryngoscope 1988;98:980-93.
3. Nonomura N, Giebink GS, Zelterman D, Harada T, Juhn SK. Early biochemical events in pneumococcal otitis media: arachidonic acid metabolites in middle ear fluid. Ann Otol Rhinol Laryngol 1991;100:385-8.
4. Brodsky L, Faden H, Bernstein J, et al. Arachidonic acid metabolites in middle ear effusions of children. Ann Otol Rhinol Laryngol 1991;100:589-92.
5. McDonald PP, McColl SR, Naccache PH, Borgeat P. Activation of the human neutrophil 5-lipoxygenase by leukotriene B4. Br J Pharmacol 1992;107:226-32.
6. Palmblad J, Malmsten CL, UdénAM, Rådmark O, Engstedt L, Samuelsson B. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood 1981; 58:658-61.
7. Villani-Price D, Yang DC, Walsh RE, et al. Multiple actions of the leukotriene B4 receptor antagonist SC-41930. J Pharmacol Exp Ther 1992;260:187-91.
8. Fretland DJ, Widomski D, Tsai BS. et al. Effect of leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit. J Pharmacol Exp Ther 1990; 255:572-6.
9. Djuric SW, Collins PW, Jones PH, et al. 7-[3-(4-Acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1- benzopyran-2-carboxylic acid: an orally active selective leukotriene B4 receptor antagonist. J Med Chem 1989;32:1145-7.
10. Kaya M, Energin F, Mensiz E, Erim A, Reis A, Arseven G. Ocular anti-inflammatory activity of SC-41930, a specific leukotriene B4 receptor antagonist. Turk J Med Sci 1993;18: 295-301.
11. Baron EJ, Finegold SM. Diagnostic microbiology. St Louis, Mo: CV Mosby, 1990:171-94.
12. 51Cr-labeled cells and myeloperoxidase. Inflammation 1983;7:247-55.
13. Pettipher ER, Salter ED, Berslow R, Raycroft L, Showell HJ. Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses. Br J Pharmacol 1993; 110:423-7.
14. Jung TTK, Hwang SJ, Olson D, et al. Effects of penicillin, ibuprofen, corticosteroid, and tympanostomy tube insertion on experimental otitis media. In: Lim DJ, Bluestone CD, Klein JO, Nelson JD, eds. Recent advances in otitis media. Philadelphia, Pa: BC Decker, 1988:231-5.
15. Boughton-Smith NK, Wallace JL, Whittle JR. Relationships between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in rat model of inflammatory bowel disease. Agents Actions 1988;25:115-23.
16. Jung TTK. Arachidonic acid metabolites in otitis media pathogenesis. Ann Otol Rhinol Laryngol 1988;97(suppl 132):14-8.
17. Jung TTK, Giebink GS, Juhn SK. Effects of ibuprofen, corticosteroid, and penicillin on the pathogenesis of experimental pneumococcal otitis media. In: Lim DJ, Bluestone CD, Klein JO, Nelson JD, eds. Recent advances in otitis media. Philadelphia, Pa: BC Decker, 1984:269-72.
18. Jung TTK, Rhee CK, Park YS, Choi DJ, Miller S, Weeks D. Effect of the inhibitors of leukotriene and platelet-activating factor on killed H influenzae-induced experimental otitis media. In: Mogi G, Honjo I, Ishii T, Takasaka T, eds. Recent advances in otitis media. Amsterdam, the Netherlands: Kugler, 1994:661-5.
19. Tsai BS, Villani-Price D, Keith RH, et al. SC-41930: an inhibitor of leukotriene B4-slimulated human neutrophil functions. Prostaglandins 1989;38:655-74.